Related Experiment Video
Updated: May 14, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Keeping an eye on the ring: COMS plaque loading optimization for improved dose conformity and homogeneity.
Nolan L Gagne1, Daniel R Cutright, Mark J Rivard
1Department of Radiation Oncology, Tufts University School of Medicine, Boston, MA, USA.
Journal of Contemporary Brachytherapy
|January 25, 2013
Summary
Optimizing radionuclide selection and source strength in COMS plaque brachytherapy improves tumor dose conformity and homogeneity. This novel method offers better treatment planning for eye plaque brachytherapy.
Area of Science:
- Medical Physics
- Radiation Oncology
- Ophthalmology
Background:
- Ocular tumors require precise radiation delivery to maximize efficacy and minimize damage to surrounding tissues.
- Current COMS plaque brachytherapy methods using (125)I offer a baseline but can be improved for dose distribution.
- Investigating alternative radionuclides and source arrangements is crucial for enhancing treatment outcomes.
Purpose of the Study:
- To enhance tumor dose conformity and homogeneity in COMS plaque brachytherapy.
- To explore the dosimetric impact of varying radionuclides and source strengths within plaque components.
- To develop a method for optimizing radionuclide selection and source arrangement for improved ocular tumor treatment.
Main Methods:
- Monte Carlo (MC) simulations using MCNP5 to model dose distributions for (103)Pd, (125)I, and (131)Cs in COMS plaques.
- MATLAB programming to generate and analyze dose distributions for various radionuclide and source strength permutations.
- Comparison of dose distributions with uniformly-loaded (125)I plaques and assessment of organ-at-risk (OAR) doses using Pinnacle(3) TPS.
Main Results:
- Centralized (103)Pd seeds (>97% strength) yielded the most conformal doses, with higher tumor basal doses and lower OAR doses.
- (131)Cs seeds (82-86% strength) in peripheral loading resulted in the most homogeneous doses, with lower tumor basal and higher OAR doses.
- MC and TPS dose distributions showed >99% agreement via gamma-index analysis.
Conclusions:
- A novel method allows for the selection of intra-plaque radionuclide compositions and source strengths to achieve superior dose conformity and homogeneity compared to standard (125)I plaques.
- This approach provides a framework for optimizing treatment planning in eye plaque brachytherapy.
- The findings support further clinical investigations into tailored treatment strategies for ocular tumors.
